Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Research programme: macrophage-based nanoparticle delivery systems - Baxter Healthcare

Drug Profile

Research programme: macrophage-based nanoparticle delivery systems - Baxter Healthcare

Alternative Names: NP-IDV-BMMs - Baxter; PTX-NP-BMMs

Latest Information Update: 08 Mar 2011

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Baxter Healthcare Corporation
  • Class Paclitaxels; Pyridines
  • Mechanism of Action HIV protease inhibitors; Tubulin inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Brain cancer; HIV-1 infections

Most Recent Events

  • 19 Nov 2008 Pharmacodynamics data from a preclinical trial in Brain cancer presented at the 38th Annual Meeting for the Society of Neuroscience (SfN-2008)
  • 07 Nov 2007 Preclinical trials in Brain cancer in USA (Parenteral)
  • 07 Nov 2007 Preclinical pharmacodynamics data presented at the 37th Annual Meeting of the Society for Neuroscience (SfN-2007)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top